Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Can Intuitive Surgical Top Expectations Yet Again? Here’s What To Watch

Published 04/19/2016, 01:16 AM
Updated 07/09/2023, 06:31 AM

Intuitive Surgical (NASDAQ:ISRG) Health Care - Health Care Equipment & Supplies | Reports April 19, After Market Closes

Key Takeaways

  • The Estimize community is calling for EPS of $4.41 on revenue expectations of 592.51, 11 cents higher than Wall Street on the bottom line and $6.5 million higher on the top
  • Intuitive Surgical’s robust growth the past year comes from the success of its surgical systems, particularly the da Vinci
  • The surgical robotics company makes its biggest margins on accessories for its systems
  • What are you expecting for ISRG?

The past year has been extremely volatile for healthcare and biotech companies. In fact, the Vanguard Health Care (NYSE:VHT) ETF, which tracks many of these stocks, is down 7.49% in the past 12 months. This hasn’t been the case for Intuitive Surgical, which has moved in the exact opposite direction. Over the same period, the stock is up 15.72% primarily due to the success of its flagship product, the da Vinci surgical system. Earnings have followed suit and have topped expectations in each of the past 3 quarters. ISRG FQ1 2016

This quarter, the Estimize community is calling for EPS of $4.41 on revenue expectations of 592.51 million, 11 cents higher than Wall Street on the bottom line and $6.5 million higher on the top. However our Select Consensus, a weighted average of our most accurate analysts and recent estimates, is calling for a larger beat of 13 cents and $7.5 million. This margin has expanded in past three months with EPS revisions increasing 4%. If all goes as expected, profitability will grow 23% on a 12% increase in revenue, year over year.

ISRG Fq1 2016 II

Intuitive Surgical’s robust growth the past year comes from the success of its surgical systems , particularly the da Vinci. In Q4 2015, the number of procedures performed with a da VInci system increased 15%. Procedures volume should continue to see these gains with expectations of increasing by 10% this year. The biggest slight against these systems have been their astronomical price tag, which could hamper sales in the near future. However, Intuitive makes its biggest margins from new accessories such as the Xi Vessel Sealer, Xi Firefly and Xi Stapler. System wide sales are expected to be carried by new accessories and have been forecasted to rise 9.6%. If Intuitive Surgical is able to successfully capitalize on widespread adoption, and global expansion, then sky’s the limit for earnings potential.

Do you think ISRG can beat estimates?

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.